Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study - Morschhauser, F; Le Gouill, S; Feugier, P (Lancet Haematol, 2019)